# Hyper-rapid progression in Salmonella-associated mycotic aortic aneurysms: a narrative review

**Authors:** Jernej Lucev, Vojko Flis, Ales Slanic, Jerneja Cujes, Silva Breznik

PMC · DOI: 10.2478/raon-2026-0016 · Radiology and Oncology · 2026-03-24

## TL;DR

This paper reviews how Salmonella infections can rapidly cause dangerous aortic aneurysms and introduces a new early warning sign for urgent treatment.

## Contribution

The paper introduces 'hyper-rapid progression' as a novel imaging biomarker for Salmonella-associated mycotic aortic aneurysms.

## Key findings

- Salmonella-associated mycotic aortic aneurysms show a high-velocity progression pattern.
- Hyper-rapid progression is defined as rapid aneurysm growth within 7 days or 72 hours despite antibiotics.
- Complex endovascular repair with optimized radial sealing is proposed as an alternative to surgery in high-risk cases.

## Abstract

Mycotic aortic aneurysms (MAAs), or infective native aortic aneurysms, are rare, life-threatening infections with a high risk of rupture. Non-typhoidal Salmonella (NTS) species show a tropism for the diseased aorta in elderly, atherosclerotic patients, causing explosive growth poorly captured by conventional surveillance. Management is complex when the visceral/paravisceral aorta is involved, making open surgical repair (OSR) risky and requiring tailored endovascular aortic repair (EVAR). This review synthesises evidence on Salmonella-associated MAAs and introduces hyper-rapid progression (HRP) as an early imaging biomarker.

Salmonella MAAs represent a high-velocity phenotype. We define HRP as progression from aortitis to saccular pseudoaneurysm (≥ 5 mm) within 7 days or rapid enlargement (≥ 5 mm or > 50%) within 72 hours despite antibiotics. HRP serves as a “red flag” for urgent mechanical stabilisation. While OSR is the gold standard, in anatomically complex or high-risk patients, complex EVAR with parallel grafts and an optimized radial sealing strategy (ORSS) offers a life-saving alternative. Prospective validation of HRP and its integration into imaging algorithms are needed to improve survival in this devastating condition.

## Linked entities

- **Species:** Salmonella (taxon 590)

## Full-text entities

- **Diseases:** Hyper (MESH:D007589), aneurysmal dilatation (MESH:D002311), AAA (MESH:C565230), thoracoabdominal disease (MESH:D058502), spondylodiscitis (MESH:D015299), staphylococcal/streptococcal aneurysms (MESH:D011023), MAAs (MESH:D000785), infectious (MESH:D003141), thoracic and paravisceral disease (MESH:D013896), Fever (MESH:D005334), hypertension (MESH:D006973), aortic involvement (MESH:C564676), pancreatitis (MESH:D010195), aortic aneurysms (MESH:D001014), gastroenteritis (MESH:D005759), MAA (MESH:C537464), periaortitis (MESH:D012185), leaks (MESH:D019559), vasculitis (MESH:D014657), reinfection (MESH:D000084063), vascular disease (MESH:D014652), endoleak (MESH:D057867), back pain (MESH:D001416), NTS (MESH:D014435), Salmonella (MESH:D012480), degenerative (MESH:D019636), chronic inflammation (MESH:D007249), Atherosclerosis (MESH:D050197), frailty (MESH:D000073496), Diabetes mellitus (MESH:D003920), pyelonephritis (MESH:D011704), visceral and paravisceral disease (MESH:D007418), chronic kidney disease (MESH:D051436), rupture-prone aneurysms (MESH:D017542), atherosclerotic plaques (MESH:D058226), ischaemia (MESH:D007511), bacteraemia (MESH:C531821), Pseudoaneurysm (MESH:D017541), atherosclerotic ulcers (MESH:D014456), HIV infection (MESH:D015658), leukocytosis (MESH:D007964), Infection (MESH:D007239), abdominal and back pain (MESH:D015746), Aortitis (MESH:D001025), Aneurysms (MESH:D000783), AAAs (MESH:C536008), rupture (MESH:D012421), flank or back pain (MESH:D021501), necrotic tissue (MESH:D017695), malignancy (MESH:D009369), abscess (MESH:D000038), disease (MESH:D004194), HRP (MESH:C564983), psoas abscess (MESH:D016659), sepsis (MESH:D018805)
- **Chemicals:** ceftriaxone (MESH:D002443), lipid (MESH:D008055), carbapenems (MESH:D015780), cephalosporins (MESH:D002511), MAAs (-), ciprofloxacin (MESH:D002939), flucloxacillin (MESH:D005436), 18F-FDG (MESH:D019788), fluoroquinolones (MESH:D024841)
- **Species:** Homo sapiens (human, species) [taxon 9606], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Salmonella (genus) [taxon 590], Staphylococcus aureus (species) [taxon 1280], Salmonella enterica subsp. enterica serovar Enteritidis (no rank) [taxon 149539]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012376/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012376/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012376/full.md

---
Source: https://tomesphere.com/paper/PMC13012376